Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The company unveiled its new modular robotic surgery system for minimally invasive surgery at a special event in Hartford, CT. Medtronic expects the new system to earn a CE mark by early 2021 and FDA approval by the end of 2021.
Latest From Market Access
With the current Brexit date less than a month away, the UK IVDs industry is busy providing support to UK manufacturers and the pathology sector in an attempt to ensure no one gets caught out. Coinciding with this are the ongoing preparations for the EU IVDR, and a raft of UK-specific issues for the diagnostics industry.
A new public consultation is looking at whether Australia’s rules prohibiting the supply of many types of self-testing IVDs are still fit for purpose.
The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.
Medicare administrative contractors for 19 US states have proposed supplying local Medicare coverage for hypoglossal nerve stimulation (HNS) provided by Inspire Medical Systems’ Inspire therapy to treat obstructive sleep apnea. See what company president and CEO Tim Herbert said about it here.
Noridian and Palmetto – two Medicare administrative contractors (MACs) serving 19 states in the West and Southeast – on 26 August proposed local coverage determinations (LCDs) for Inspire Medical Systems Inc.’s hypoglossal nerve stimulation devices to treat obstructive sleep apnea.
UK NHS is now using a blood test developed by Roche Diagnostics for predicting pre-eclampsia in pregnant women.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.